Electroencephalography (EEG) Systems Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (8-channel EEG, 21-channel EEG, 25 channel EEG, 32-channel EEG, 40-channel EEG, Multi-channel EEG), By Applications (Hospitals, Diagnostic Centers, Others), and Regional Insights and Forecast to 2035

Electroencephalography (EEG) Systems Size

The Global Electroencephalography (EEG) Systems Market size was USD 455.55 million in 2025 and is projected to reach USD 482.43 million in 2026 and USD 803.69 million by 2035, exhibiting a CAGR of 5.9% during the forecast period from 2026 to 2035. Expansion is being supported by broader neurological testing capacity, continuous brain monitoring, epilepsy diagnostics, critical-care EEG adoption, and increasing integration of digital interpretation tools.

The Electroencephalography (EEG) Systems Market is shifting from conventional scheduled diagnostic testing toward connected neurological monitoring that can support routine examinations, epilepsy monitoring units, critical care, ambulatory services, and research environments. Hospitals account for an estimated 59% of system demand, while multi-channel and advanced 32-channel configurations together represent roughly 47% of equipment adoption. Procurement decisions increasingly consider interoperability, remote review, electrode workflow, signal quality, patient mobility, and software compatibility rather than amplifier specifications alone.

The U.S. Electroencephalography (EEG) Systems Market remains a major adoption center because large hospital networks, epilepsy centers, emergency departments, academic institutions, and outpatient neurological practices maintain comparatively mature EEG infrastructure. The country represents an estimated 31% of global system demand, while more than 44% of U.S. replacement purchasing is increasingly influenced by workflow automation, remote interpretation, point-of-care monitoring, or ambulatory functionality. Growth is also being shaped by pressure to shorten neurological assessment times, expand technician productivity, and make EEG acquisition practical outside dedicated neurodiagnostic laboratories.

Key Findings

• Starting at USD 455.55 million in 2025, the global Electroencephalography (EEG) Systems Market is set to witness steady growth. By 2026, it is projected to reach USD 482.43 million, further expand to USD 510.89 million in 2027, and reach USD 803.69 million by 2035. The market is expected to grow at a CAGR of 5.9% throughout the forecast period from 2026 to 2035.
• Demand for EEG systems is rising due to increasing prevalence of neurological disorders, growing need for epilepsy diagnosis, expansion of critical-care monitoring, and rising adoption of ambulatory and sleep-related neurodiagnostic testing. Advanced and multi-channel EEG platforms account for an estimated 47% of current system demand.
• Electroencephalography (EEG) systems play a vital role in modern neurological care by enabling real-time brain activity monitoring, seizure detection, long-term patient observation, and clinical decision support. These capabilities enhance diagnostic accuracy, improve patient outcomes, and support advanced neurophysiological research.
• Regulatory focus on medical device safety, software validation, cybersecurity, and clinical performance is shaping market development. Approximately 38% of procurement evaluations now place increased emphasis on data integrity, interoperability, and compliance with evolving digital health standards.
• North America accounts for 38% of the global market, supported by advanced healthcare infrastructure, strong neurological research activity, and widespread adoption of digital EEG systems. Asia-Pacific is the fastest-growing region due to expanding healthcare access, rising neurological disease burden, and increasing investment in hospital infrastructure and diagnostic capabilities.

EEG purchasing differs from many diagnostic-device categories because clinical value depends heavily on the combined performance of amplifiers, electrodes, acquisition software, review platforms, technician workflow, and neurologist interpretation. An estimated 42% of competitive differentiation is now associated with software usability, connectivity, data review, and workflow support rather than hardware specifications alone. Hospitals also increasingly evaluate lifetime system utilization, with about 36% of purchasing teams favoring scalable platforms that can serve routine EEG, long-term monitoring, ICU applications, or ambulatory workflows through a common software environment.

Electroencephalography (EEG) Systems Market Trends

The strongest Electroencephalography (EEG) Systems Market trend is the movement toward faster, distributed, and more continuous neurological monitoring. Traditional EEG remains essential for routine neurological evaluation, but clinical demand is expanding toward emergency departments, intensive care units, ambulatory settings, epilepsy monitoring units, and home-based diagnostic workflows. Multi-channel platforms account for an estimated 25% of current market demand, while 32-channel equipment contributes another 22%, illustrating buyer preference for systems that combine sufficient clinical resolution with practical workflow flexibility. Hospitals are also prioritizing wireless connectivity, compact amplifiers, synchronized video, remote review, cloud-compatible data transfer, and simplified electrode setup. These changes are particularly relevant where neurological expertise is centralized but acquisition occurs across multiple facilities. Clinical organizations increasingly want systems that allow EEG technicians to manage recordings efficiently while neurologists review studies remotely without interrupting acquisition.

Artificial intelligence and quantitative EEG tools are also changing purchasing criteria, although clinicians continue to treat automated interpretation as decision support rather than a substitute for specialist review. Roughly 39% of advanced EEG procurement evaluations now consider automated event detection, trend visualization, seizure screening, or quantitative review capabilities as meaningful differentiators. At the same time, an estimated 33% of healthcare buyers are placing increased weight on interoperability with electronic clinical systems, centralized neurodiagnostic databases, and enterprise monitoring platforms. The result is a market in which software ecosystems, cybersecurity readiness, remote-access design, and upgrade pathways increasingly influence hardware selection. Ambulatory EEG is another important trend because longer recordings may capture intermittent neurological events that short routine examinations can miss. Vendors are therefore balancing higher channel density and analytical sophistication with portability, battery endurance, patient comfort, simplified setup, and reduced technician intervention.

Electroencephalography (EEG) Systems Market Dynamics

OPPORTUNITY

Expansion of ambulatory and point-of-care neurological monitoring

Portable EEG, wireless acquisition, remote interpretation, and rapid-deployment systems are widening the addressable clinical environment beyond dedicated neurology laboratories. About 34% of incremental purchasing opportunity is associated with ambulatory, intensive-care, emergency, and decentralized neurological monitoring, while close to 29% of prospective buyers identify faster setup and remote access as important operational criteria. Vendors capable of combining clinically useful signal quality with simplified electrode application, compact hardware, synchronized video, and centralized interpretation can address hospitals that need neurological coverage without maintaining a dedicated EEG team at every location.

DRIVERS

Increasing clinical use of EEG across neurological care pathways

The principal growth driver is broader EEG utilization in epilepsy assessment, altered mental status, seizure monitoring, encephalopathy evaluation, critical-care surveillance, and long-term neurological observation. Hospitals represent about 59% of system demand, demonstrating the importance of inpatient neurological infrastructure, while diagnostic centers account for an estimated 28%. Greater awareness of non-convulsive seizures and the value of continuous neurological monitoring is encouraging hospitals to deploy EEG beyond traditional laboratories. This creates demand for systems that support routine studies, long-duration recordings, remote access, video synchronization, quantitative trending, and scalable channel configurations.

Market Restraints

"Specialist staffing and capital-allocation constraints"

EEG expansion is restrained by shortages of trained technologists, neurologists, neurophysiologists, and personnel capable of managing long-duration recordings. An estimated 31% of healthcare facilities evaluating expanded EEG programs identify specialized staffing availability as a material limitation, while about 24% face competition for capital from imaging, monitoring, surgical, and broader digital-health investments. Complex electrode placement and lengthy recordings can also reduce throughput. Systems that simplify setup, enable remote review, improve artifact management, or support technician productivity can mitigate these issues, but staffing remains an operational bottleneck that hardware investment alone cannot fully resolve.

Market Challenges

"Balancing advanced analytics with clinical trust and interoperability"

A major challenge is converting sophisticated EEG analytics into tools that clinicians can use reliably within established care pathways. Roughly 37% of advanced-system evaluations place substantial importance on interoperability with existing clinical infrastructure, while about 27% of buyers remain cautious about workflows that depend heavily on automated interpretation. Vendors must demonstrate signal integrity, transparent data processing, cybersecurity, reliable integration, and clinically understandable outputs. Another challenge is supporting mixed fleets of legacy and newer equipment. Hospitals may resist platform changes if data migration, technician retraining, electrode compatibility, or software integration disrupt existing neurodiagnostic operations.

Segmentation Analysis

The Electroencephalography (EEG) Systems Market is segmented by channel configuration and clinical application because purchasing requirements vary substantially across routine testing, epilepsy monitoring, research, intensive care, ambulatory diagnostics, and specialized neurophysiology. Multi-channel systems account for an estimated 25% of demand, followed by 32-channel platforms at 22% and 21-channel systems at 20%. From an application perspective, hospitals dominate with roughly 59% of demand because they operate neurological departments, emergency units, intensive-care services, epilepsy monitoring programs, and long-term monitoring facilities. Diagnostic centers contribute about 28%, while research, ambulatory, specialty, and other settings collectively represent 13%.

By Type

8-channel EEG: Eight-channel systems serve focused neurological monitoring, compact diagnostic configurations, anesthesia-related brain monitoring, educational applications, and selected point-of-care workflows where full conventional EEG coverage is not required. The category benefits from lower equipment complexity and faster setup, although its diagnostic scope is narrower than higher-channel configurations. It represents close to 10% of market demand, while about 21% of buyers considering lower-channel products prioritize portability and simplified operation over maximum electrode density.

The 8-channel Electroencephalography (EEG) Systems segment is estimated at USD 48.24 million in 2026, representing 10% market share. The segment is modeled to expand at a 4.2% CAGR through 2035 as compact systems retain demand in focused neurological monitoring, perioperative applications, training environments, and selected decentralized care settings.

21-channel EEG: Twenty-one-channel EEG platforms remain closely aligned with established routine diagnostic practices and conventional scalp-electrode workflows. Their familiarity among neurodiagnostic departments makes them practical for general EEG examinations, outpatient neurological assessment, and standard epilepsy investigations. This category accounts for an estimated 20% of market demand, while roughly 32% of routine EEG purchasing decisions continue to favor configurations that support recognized clinical montages without adding unnecessary hardware complexity.

The 21-channel Electroencephalography (EEG) Systems segment is estimated at USD 96.49 million in 2026, equal to 20% of the global market. A modeled 5.3% CAGR through 2035 reflects steady replacement demand, continuing use in routine neurological diagnostics, and broader adoption in hospitals and diagnostic centers seeking standardized clinical EEG functionality.

25 channel EEG: Twenty-five-channel systems occupy a flexible position between conventional routine EEG and more extensively instrumented monitoring. Buyers use these platforms when additional physiological inputs, recording flexibility, or expanded clinical protocols are needed without moving to very high channel density. The category represents about 12% of market demand, and an estimated 26% of installations are associated with facilities that want one platform to support multiple routine and extended neurodiagnostic workflows.

The 25 channel Electroencephalography (EEG) Systems segment is estimated at USD 57.89 million in 2026, corresponding to 12% market share. It is modeled to record a 4.8% CAGR through 2035, supported by replacement cycles and demand for mid-range configurations that offer more recording flexibility while maintaining manageable system complexity.

32-channel EEG: Thirty-two-channel EEG systems are among the most commercially important configurations because they combine broad clinical capability with manageable setup requirements. They are widely relevant to routine EEG, ICU monitoring, long-term recordings, ambulatory studies, and clinical research. The category contributes an estimated 22% of global demand, while about 41% of advanced hospital evaluations consider 32-channel capability sufficient for a broad range of non-invasive diagnostic protocols.

The 32-channel Electroencephalography (EEG) Systems segment is estimated at USD 106.13 million in 2026, representing 22% of market demand. The category is modeled at a 6.0% CAGR through 2035 as hospitals standardize flexible platforms capable of serving routine testing, prolonged monitoring, portable acquisition, and integrated video-EEG workflows.

40-channel EEG: Forty-channel platforms address facilities requiring expanded physiological recording, additional referential or bipolar inputs, research flexibility, and more complex neurological investigations. The segment is smaller than mainstream 21-channel and 32-channel categories but remains relevant to specialist centers and advanced laboratories. It represents close to 11% of global demand, with about 28% of its purchasing activity concentrated in academic, tertiary-care, or specialist neurodiagnostic environments.

The 40-channel Electroencephalography (EEG) Systems segment is estimated at USD 53.07 million in 2026 and accounts for 11% market share. A modeled 5.4% CAGR through 2035 is supported by specialist clinical applications, advanced physiological recording requirements, and research facilities seeking additional flexibility beyond standard routine EEG configurations.

Multi-channel EEG: Multi-channel EEG systems include high-density and expandable platforms designed for epilepsy monitoring, cortical mapping, intracranial monitoring, advanced neuroscience, and complex long-term recording. These systems command the largest modeled type share at 25% because high-capability centers increasingly value scalability and advanced signal acquisition. About 43% of specialist neurophysiology buyers prioritize upgradeable channel capacity, synchronized video, analytical software, or integration with stimulation and research workflows.

The multi-channel Electroencephalography (EEG) Systems segment is estimated at USD 120.61 million in 2026, representing 25% of global demand. It is modeled to grow at a 7.1% CAGR through 2035, making it the fastest-growing type category as epilepsy centers, research institutes, and tertiary hospitals expand high-density and long-term neurological monitoring capabilities.

By Application

Hospitals: Hospitals are the principal application segment because EEG is integrated into neurology departments, emergency care, intensive-care units, epilepsy programs, operating environments, neonatal monitoring, and inpatient diagnostic pathways. Large institutions increasingly favor platforms that support multiple use cases through shared software and centralized review. Hospitals account for an estimated 59% of demand, while about 46% of advanced procurement activity prioritizes continuous monitoring, remote interpretation, or system integration capabilities.

The hospital Electroencephalography (EEG) Systems segment is estimated at USD 284.63 million in 2026, equivalent to 59% of global market demand. It is modeled to expand at a 6.2% CAGR through 2035 as continuous EEG, epilepsy monitoring, critical-care neurodiagnostics, and enterprise neurological data management become more widely integrated into hospital workflows.

Diagnostic Centers: Diagnostic centers use EEG primarily for scheduled neurological evaluations, seizure investigations, outpatient testing, sleep-related assessments, and physician-referred neurodiagnostic services. Their purchasing priorities typically emphasize patient throughput, reliability, technician usability, manageable operating costs, and standardized reporting. This application represents about 28% of demand, and nearly 35% of diagnostic-center purchasing evaluations give particular importance to rapid setup and efficient review workflows.

The diagnostic-center Electroencephalography (EEG) Systems segment is estimated at USD 135.08 million in 2026, representing 28% market share. A modeled 5.2% CAGR through 2035 reflects steady growth in outpatient neurological testing, expansion of independent neurodiagnostic services, and replacement of aging digital EEG infrastructure.

Others: Other applications include academic research institutions, ambulatory EEG providers, home-monitoring programs, specialty clinics, pharmaceutical research, neuroscience laboratories, and selected perioperative environments. Although fragmented, this group is strategically important because it often adopts portable, high-density, wearable, or specialized EEG technology earlier than conventional settings. The category contributes about 13% of demand, while close to 31% of its purchasing activity is associated with portable or research-oriented configurations.

The other-applications Electroencephalography (EEG) Systems segment is estimated at USD 62.72 million in 2026, equal to 13% of market demand. It is modeled to expand at a 6.6% CAGR through 2035 as ambulatory diagnostics, neuroscience research, decentralized monitoring, wearable acquisition, and specialized neurological programs broaden the range of environments in which EEG systems are deployed.

Electroencephalography (EEG) Systems Market Regional Outlook

Regional performance in the Electroencephalography (EEG) Systems Market reflects differences in hospital infrastructure, neurological specialist availability, reimbursement, research intensity, device replacement cycles, and access to advanced epilepsy care. North America leads with an estimated 38% share, followed by Europe at 27%, Asia-Pacific at 26%, and Middle East & Africa at 9%. Mature markets are driven largely by replacement, software upgrades, continuous monitoring, and advanced ambulatory applications, while developing healthcare systems generate proportionally greater demand from new neurological capacity, specialist hospital expansion, and broader access to diagnostic equipment.

North America

North America maintains the strongest position because of its concentration of tertiary hospitals, epilepsy centers, clinical research organizations, neurological specialists, and established EEG replacement cycles. Buyers increasingly prioritize point-of-care monitoring, remote review, enterprise connectivity, and systems capable of serving several neurological departments. The region accounts for approximately 38% of global demand, while an estimated 45% of advanced procurement decisions include remote access, quantitative analysis, or integrated data-management capabilities as important selection factors.

North America represents an estimated USD 183.32 million of the Electroencephalography (EEG) Systems Market in 2026, equivalent to 38% share. Continued replacement of legacy EEG infrastructure, expansion of critical-care monitoring, ambulatory diagnostics, and adoption of connected neurological systems are expected to preserve the region's leading position.

Europe

Europe maintains a mature neurodiagnostic ecosystem supported by public hospitals, academic medical centers, epilepsy programs, and strong clinical neurophysiology practices. Procurement is influenced by device regulation, interoperability, data protection, service availability, and lifecycle support. Europe represents about 27% of global demand, with an estimated 34% of system evaluations placing high importance on software longevity, cybersecurity, upgradeability, and vendor support alongside traditional signal-quality specifications.

Europe is estimated at USD 130.26 million in 2026, representing 27% of the Electroencephalography (EEG) Systems Market. Replacement demand, clinical-standardization programs, epilepsy diagnostics, digital hospital investment, and growing interest in ambulatory neurological monitoring are expected to support steady regional expansion.

Asia-Pacific

Asia-Pacific is becoming increasingly important as large hospital networks expand neurological services and major urban medical centers invest in epilepsy diagnosis, critical care, sleep medicine, and neuroscience research. Market development remains uneven, but the installed base is broadening across both premium and cost-sensitive healthcare systems. Asia-Pacific accounts for roughly 26% of global demand, while about 37% of incremental regional purchasing is associated with new capacity rather than straightforward replacement.

Asia-Pacific is estimated at USD 125.43 million in 2026, corresponding to 26% of the Electroencephalography (EEG) Systems Market. Rising diagnostic access, hospital modernization, specialist training, local distribution expansion, and increasing demand for scalable EEG systems position the region for faster share gains over the forecast horizon.

Middle East & Africa

Middle East & Africa remains a smaller but developing EEG market shaped by concentrated investment in tertiary hospitals, private healthcare networks, teaching institutions, and neurological centers. Premium adoption is strongest in well-funded metropolitan healthcare systems, while broader penetration is constrained by specialist availability and procurement budgets. The region represents about 9% of global demand, with close to 23% of purchasing opportunities linked to newly established or expanded neurological diagnostic departments.

Middle East & Africa is estimated at USD 43.42 million in 2026, equivalent to 9% of the Electroencephalography (EEG) Systems Market. Hospital expansion, specialist-care investment, neurological awareness, and gradual improvements in neurodiagnostic access are expected to support a larger installed base despite uneven adoption between countries.

List of Key Electroencephalography (EEG) Systems Market Companies Profiled

Investment Analysis and Opportunities

Investment in the Electroencephalography (EEG) Systems Market is increasingly directed toward software-rich platforms, ambulatory monitoring, point-of-care EEG, high-density acquisition, remote neurological review, and workflow automation. An estimated 34% of strategic investment opportunity relates to portable or decentralized monitoring because hospitals are looking for ways to extend EEG access beyond dedicated neurodiagnostic laboratories. Another 28% is associated with analytics, quantitative EEG, automated screening, centralized data management, and clinical decision-support functionality. These areas are attractive because software capabilities can improve the utilization of installed hardware while creating longer-term relationships between vendors and healthcare institutions.

Emerging markets also provide meaningful opportunities for manufacturers that can balance performance, serviceability, and acquisition cost. About 31% of future capacity-oriented purchasing is expected to arise from hospital networks adding new neurological services rather than simply replacing existing platforms. Investors are therefore focusing on distribution networks, technician training, localized regulatory support, electrode consumables, and modular product families. Higher-value opportunities exist where a supplier can combine EEG acquisition, synchronized video, long-term monitoring, data-management software, portable hardware, and service support. Platforms with shared architecture can reduce training requirements and encourage hospitals to standardize more of their neurological workflow with a single supplier, potentially improving vendor retention by more than 22% compared with fragmented equipment strategies.

New Products Development

New product development in the Electroencephalography (EEG) Systems Market is centered on making neurological monitoring faster to deploy, easier to operate, and more accessible outside conventional EEG laboratories. Approximately 36% of current development priorities relate to portable, wireless, wearable, or point-of-care configurations. Manufacturers are reducing amplifier size, improving battery operation, simplifying electrode application, and integrating remote-control capabilities so recordings can be performed in emergency departments, intensive-care units, ambulatory environments, and patient homes. These improvements are particularly important where EEG technologists are scarce or neurological interpretation must be provided from another location.

Software development represents another significant innovation area, accounting for an estimated 41% of product differentiation in advanced purchasing evaluations. Vendors are enhancing seizure-detection assistance, quantitative trending, artifact review, centralized study management, synchronized video, remote interpretation, cybersecurity, and interoperability with hospital information environments. High-density systems are simultaneously improving sampling capability and scalability for research, epilepsy monitoring, brain mapping, and advanced neurophysiology. Product design is therefore becoming less centered on channel count alone. Successful platforms increasingly combine dependable signal acquisition with technician-friendly setup, clinician-oriented analytics, scalable storage, remote connectivity, and upgradeable software. About 33% of buyers now evaluate future software compatibility and update pathways as closely as immediate amplifier performance.

Recent Developments

• May 2025– Natus Medical expanded point-of-care EEG with BrainWatch: Natus announced the commercial launch of its BrainWatch wearable point-of-care EEG platform for critical-care settings after its earlier regulatory clearance. The system is designed for rapid application and integration with established EEG workflows, strengthening Natus' position in emergency and ICU neurological monitoring. Analyst modeling suggests point-of-care solutions could widen the addressable acute-care EEG opportunity by roughly 6.4% as hospitals seek faster access to seizure assessment.

• April 2025– Cadwell invested in Seer Medical to expand home-based epilepsy diagnostics: Cadwell announced a strategic investment in Seer Medical, reinforcing its interest in longer-duration, home-oriented neurological diagnostics and remote EEG workflows. The move aligns with growing provider preference for collecting clinically useful neurological data outside traditional inpatient environments. Analyst estimates indicate home and ambulatory EEG could account for about 8.7% of incremental system-related demand as decentralized diagnostic pathways gain acceptance.

• April 2025– Nihon Kohden advanced remote neurological assessment: Nihon Kohden introduced its second-generation Live View Panel Pro virtual health system, strengthening remote neurophysiological assessment capabilities and supporting distributed neurological expertise. The development reflects a broader shift toward remote review and connected clinical workflows. Remote neurological capabilities are estimated to influence about 11.6% of advanced EEG purchasing decisions where hospitals need specialist coverage across multiple facilities or critical-care areas.

• November 2024– Nihon Kohden strengthened epilepsy diagnostics through Ad-Tech acquisition: Nihon Kohden acquired a 71.4% stake in the parent company of Ad-Tech Medical Instrument Corporation, combining established EEG expertise with specialized intracranial electrodes used in epilepsy diagnostics, brain mapping, and related procedures. The transaction strengthens an end-to-end epilepsy-care strategy and supports deeper participation in specialist monitoring environments, where invasive and high-channel-count procedures represent an estimated 7.9% of advanced EEG opportunity.

• December 2024– Natus debuted BrainWatch following regulatory clearance: Natus presented BrainWatch as a wearable point-of-care EEG platform after receiving U.S. clearance in November 2024. The system was designed for rapid deployment in acute-care environments and to integrate with established neurodiagnostic workflows. The development highlighted growing competition in simplified EEG acquisition, a product category estimated to influence approximately 9.3% of future hospital system upgrades as emergency and ICU monitoring expands.

Report Coverage

The Electroencephalography (EEG) Systems Market report evaluates market structure across channel configurations, applications, regional adoption patterns, competitive positioning, technology development, investment priorities, and procurement behavior. Type analysis covers 8-channel EEG, 21-channel EEG, 25 channel EEG, 32-channel EEG, 40-channel EEG, and multi-channel EEG systems, representing 100% of the modeled equipment market. Application analysis examines hospitals, diagnostic centers, and other settings, with hospitals accounting for an estimated 59% of demand and diagnostic centers representing 28%. The assessment considers both conventional routine EEG and expanding use cases such as epilepsy monitoring, critical-care surveillance, ambulatory recording, high-density acquisition, and point-of-care neurological assessment.

Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa, with North America estimated at 38% share and Asia-Pacific at 26%. Competitive coverage includes Natus Medical, Inc., Electrical Geodesics, Inc., Medtronic, NeuroWave Systems, Inc., Compumedics Ltd., Noraxon U.S.A., Inc., Cadwell Laboratories, Inc., and Nihon Kohden America, Inc. The report also evaluates technology variables including wireless acquisition, electrode workflow, remote monitoring, quantitative EEG, synchronized video, interoperability, cybersecurity, and software-driven clinical decision support. Approximately 41% of advanced product differentiation is modeled as increasingly software- and workflow-related, while 34% of incremental opportunity is connected to decentralized or portable monitoring. The coverage is designed to support strategic planning, competitive benchmarking, product positioning, investment assessment, distribution planning, and evaluation of changing clinical adoption patterns across the Electroencephalography (EEG) Systems Market.